NDC 65862-526 – Pioglitazone Hydrochloride and Metformin Hydrochloride
Pioglitazone Hydrochloride 15 mg/1; Metformin Hydrochloride 850 mg/1 · Tablet, Film Coated · Oral
Product NDC65862-526
Product details
- Brand name
- Pioglitazone Hydrochloride and Metformin Hydrochloride
- Generic name
- Pioglitazone Hydrochloride and Metformin Hydrochloride
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- ANDA · ANDA200823
- Marketed since
- February 13, 2013
- Listing expires
- December 31, 2027
- Pharmacologic class
- Biguanide; Peroxisome Proliferator Receptor alpha Agonist; Peroxisome Proliferator Receptor gamma Agonist; Thiazolidinedione
Active ingredients
- Pioglitazone Hydrochloride 15 mg/1
- Metformin Hydrochloride 850 mg/1
Uses, dosage, side effects and warnings for Pioglitazone Hydrochloride and Metformin Hydrochloride →
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 65862-526-18 | 180 TABLET, FILM COATED in 1 BOTTLE (65862-526-18) | Feb 13, 2013 |
| 65862-526-60 | 60 TABLET, FILM COATED in 1 BOTTLE (65862-526-60) | Feb 13, 2013 |
Other Pioglitazone Hydrochloride and Metformin Hydrochloride products
- 65862-525 Pioglitazone Hydrochloride 15 mg/1; Metformin Hydrochloride 500 mg/1 · Tablet, Film Coated · Aurobindo Pharma Limited
- 57237-217 Pioglitazone Hydrochloride 15 mg/1; Metformin Hydrochloride 500 mg/1 · Tablet, Film Coated · Rising Pharma Holdings, Inc.
- 57237-218 Pioglitazone Hydrochloride 15 mg/1; Metformin Hydrochloride 850 mg/1 · Tablet, Film Coated · Rising Pharma Holdings, Inc.